| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cd6979b05020fb18f7526390988a8650 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-912 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0051
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0668 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-50 |
| filingDate |
2020-10-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_278e6000692303cb31bcbd6ecf12aa1d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd4225e440975a28167f6ceb688e60a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ccd5d4d8dc68247fc3c2bb0b7f327d7 |
| publicationDate |
2020-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20200124202-A |
| titleOfInvention |
A composition comprising mesenchymal stem cell derived from chorionic plate expressing CD90, CD146, CD105 or CD73 for treating thyroid associated ophthalmopathy |
| abstract |
It provides a composition for preventing, improving, or treating thyroid eye disease comprising mesenchymal stem cells as an active ingredient. The pharmaceutical composition for treating thyroid eye disease containing mesenchymal stem cells as an active ingredient restores abnormal hyaluronic acid production, increased adipocyte differentiation, and increased lipid accumulation in orbital fibroblasts in patients with thyroid eye disease. It can be usefully used to treat eye diseases. |
| priorityDate |
2017-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |